2BB score and signals
Akebia Therapeutics, Inc.’s current 2BB score is 45 out of 100, built from the signal categories below.
| Signal | Score | Reading |
|---|
| Activity | 54 | Moderate |
| Momentum | 44 | Stable |
| Financial strength | 29 | Weak |
| Quality | 93 | Very Strong |
| Risk | 29 | Low |
Company facts
| Headquarters | Cambridge, Massachusetts, United States |
| Founded | Jan 1, 2007 |
| Employees | 194 |
| 52-week range | $0.70 – $3.18 |
Recent earnings
| Report date | EPS actual | EPS estimate | Revenue actual | Revenue estimate |
|---|
| 2027-02-24 | — | -0.0408 | — | $49.15M |
| 2026-10-29 | — | -0.0374 | — | $47.88M |
| 2026-08-05 | — | -0.0449 | — | $49.84M |
| 2026-05-07 | -0.03 | -0.0286 | $53.54M | $52.70M |
Related companies
